Patent details

EP3199203 Title: SUBSTITUTED XANTHINE DERIVATIVES

Basic Information

Publication number:
EP3199203
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171608821
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED XANTHINE DERIVATIVES
French Title of Invention:
DÉRIVÉS DE XANTHINE SUBSTITUÉS
German Title of Invention:
SUBSTITUIERTE XANTHINDERIVATE
SPC Number:

Dates

Filing date:
27/02/2009
Grant date:
05/02/2020
EP Publication Date:
02/08/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/02/2020
EP B1 Publication Date:
05/02/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/02/2020
Expiration date:
27/02/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/01/2020
 
 

Name:
Concert Pharmaceuticals Inc.
Address:
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421, United States (US)

Inventor

1

Name:
TUNG, Roger, D.
Address:
United States (US)

2

Name:
LIU, Julie, F.
Address:
United States (US)

3

Name:
HARBESON, Scott, L.
Address:
United States (US)

Priority

1

Priority Number:
67736 P
Priority Date:
29/02/2008
Priority Country:
United States (US)

2

Priority Number:
134568 P
Priority Date:
11/07/2008
Priority Country:
United States (US)

3

Priority Number:
198715 P
Priority Date:
07/11/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/522; A61P 1/16; A61P 13/12; C07D 473/06;

Publication

European Patent Bulletin

Issue number:
202006
Publication date:
05/02/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages